<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 24-year-old male patient seropositive for the human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus with Burkitt's <z:hpo ids='HP_0001909'>Leukemia</z:hpo> was treated successfully with aggressive systemic chemotherapy and central <z:mp ids='MP_0008912'>nervous</z:mp> system prophylaxis </plain></SENT>
<SENT sid="1" pm="."><plain>He presented with a leukocyte count of 68,900/microliter with 33% L3 lymphoblasts, massive <z:hpo ids='HP_0001433'>hepatosplenomegaly</z:hpo>, <z:hpo ids='HP_0008940'>generalized lymphadenopathy</z:hpo>, a lactic dehydrogenase level of 9105 IU/l, <z:chebi fb="0" ids="16737">creatinine</z:chebi> level of 5.8 mg/dl, and a <z:chebi fb="3" ids="27226">uric acid</z:chebi> level of 43.5 mg/dl </plain></SENT>
<SENT sid="2" pm="."><plain>Hemodialysis, intrathecal <z:chebi fb="0" ids="44185">methotrexate</z:chebi>, <z:chebi fb="2" ids="17650">hydrocortisone</z:chebi> and <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi>, and fractionated doses of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> followed by <z:chebi fb="0" ids="28445">vincristine</z:chebi> and <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> were promptly instituted </plain></SENT>
<SENT sid="3" pm="."><plain>He received eight subsequent courses of chemotherapy consisting of either <z:chebi fb="0" ids="44185">methotrexate</z:chebi> with leucovorin rescue and high dose, continuous infusion <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> or <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, <z:chebi fb="0" ids="28445">vincristine</z:chebi>, and <z:chebi fb="0" ids="44185">methotrexate</z:chebi> with leucovorin </plain></SENT>
<SENT sid="4" pm="."><plain>There was marked hematologic toxicity resulting from this treatment </plain></SENT>
<SENT sid="5" pm="."><plain>However, the patient was alive and in complete remission more than 6 years from diagnosis </plain></SENT>
<SENT sid="6" pm="."><plain>This paper demonstrated that it is possible to successfully treat a patient who is HIV-1 antibody positive with poor prognosis Burkitt's <z:hpo ids='HP_0001909'>Leukemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Further studies need to be undertaken to define the least toxic, most effective therapy for this disease </plain></SENT>
</text></document>